Organization Overview
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
autologous microbiome (2 trials)
bifidobacterium bifidum (1 trial)
bifidobacterium lactis (1 trial)
bovine plasma protein (1 trial)
enterococcus faecium (1 trial)
fish oil (Omegavan) (2 trials)
fructo-oligosaccharide (2 trials)
galactooligosaccharide (4 trials)
gamma-aminobutyric acid (1 trial)
guava leaves extract (1 trial)
human rotavirus, live attenuated (Rotarix) (1 trial)
icosapent ethyl (vascepa) (1 trial)
Lactobacillus acidophilus (1 trial)
lactobacillus brevis (1 trial)
Cognitive Dysfunction (Phase 1)
Delirium (Phase 4)
Malaria (Phase 4)
Osteoporosis (Phase 1)
Psychomotor Agitation (Phase 4)
Substance Withdrawal Syndrome (Phase 4)
Vitamin D Deficiency (Phase 3)